Drug intelligence / Profile preview

Leukotriene D4

Development stage
Preclinical
Modality
Small Molecules
Administration
Inhalation, Intranasal, Intravenous
01

Overview

Leukotriene D4 (LTD4) is a naturally occurring cysteinyl leukotriene and a potent inflammatory mediator. It is produced in the body from arachidonic acid via the lipoxygenase pathway and acts primarily as a bronchoconstrictor agent, inducing contraction of smooth muscle in the airways and vasculature, increasing vascular permeability, promoting edema, eosinophil migration, mucus secretion, and contributing to tissue inflammation. Its effects are mediated through high-affinity binding to the cysteinyl leukotriene receptor 1 (CysLT1), a G-protein-coupled receptor that activates downstream signaling pathways such as phosphatidylinositol-calcium second messenger systems. Leukotriene D4 plays an important role in conditions like asthma and allergic rhinitis by sustaining inflammatory responses[1][2][3][5][6]. It has been used experimentally in diagnostic trials for asthma and allergic rhinitis[1][2].

Other names
leukotriene D4LTD4LTD-4LTD 4leukotriene DLeukotriene D(sub 4)
02

Targets

CYSLTR1 (Cysteinyl-leukotriene type 1 receptor)CYSLTR2 (Cysteinyl leukotriene receptor 2)

Beyond the preview

Go deeper on Leukotriene D4.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leukotriene D4.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call